Influence of the Nitric Oxide Synthase T-786C Polymorphism on the Response to Acute Inhibition of Phosphodiesterase 5 in Resistant Hypertension
Phase of Trial: Phase IV
Latest Information Update: 29 Oct 2012
At a glance
- Drugs Sildenafil (Primary)
- Indications Resistant hypertension
- Focus Pharmacodynamics; Pharmacogenomic
- Acronyms FAPESP
- 29 Oct 2012 Primary outcome amended as reported by ClinicalTrials.gov.
- 01 Sep 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 15 Jul 2011 New trial record